PerspectivePUBLIC HEALTH

Multicriteria decision analysis and core values for enhancing vaccine-related decision-making

See allHide authors and affiliations

Science Translational Medicine  29 Jun 2016:
Vol. 8, Issue 345, pp. 345ps14
DOI: 10.1126/scitranslmed.aaf0756

Article Information

vol. 8 no. 345 345ps14

DOI: 
https://doi.org/10.1126/scitranslmed.aaf0756
PubMed: 
27358496
Published By: 
American Association for the Advancement of Science
Print ISSN: 
1946-6234
Online ISSN: 
1946-6242
History: 
    Copyright & Usage: 
    Copyright © 2016, American Association for the Advancement of Science

    Author Information

    1. Michèle A. Barocchi1,
    2. Steve Black2 and
    3. Rino Rappuoli1,*
    1. 1GSK Vaccines, Via Fiorentina 1, 53100 Siena, Italy.
    2. 2Center for Global Health, Cincinnati Children’s Hospital, Cincinnati, OH 45229, USA.
    1. ↵*Corresponding author. Email: rino.r.rappuoli{at}gsk.com

    Altmetric

    Article usage

    Article usage: June 2016 to May 2019

    AbstractFullPdf
    Jun 2016878159136
    Jul 20161706521350
    Aug 20161174751
    Sep 2016893936
    Oct 2016643171
    Nov 20161073562
    Dec 2016703058
    Jan 2017773228
    Feb 2017693228
    Mar 2017582761
    Apr 2017662912
    May 2017542030
    Jun 2017612027
    Jul 2017661316
    Aug 2017621719
    Sep 2017602115
    Oct 2017621518
    Nov 2017632012
    Dec 2017562934
    Jan 2018462140
    Feb 2018491615
    Mar 2018641918
    Apr 2018512739
    May 2018522318
    Jun 2018482412
    Jul 2018381825
    Aug 201887821
    Sep 2018911724
    Oct 201869216
    Nov 2018111814
    Dec 2018911320
    Jan 2019711810
    Feb 20191312019
    Mar 20191711615
    Apr 20191511132
    May 20198356

    View Full Text

    Article Tools

    • Email
    • Download Powerpoint
    • Print
    • Alerts

    • Citation tools

    • Multicriteria decision analysis and core values for enhancing vaccine-related decision-making

      By Michèle A. Barocchi, Steve Black, Rino Rappuoli

      Science Translational Medicine : 345ps14

      Prioritization of vaccine development requires multicriteria decision-making based on disease severity, vaccine safety, and economic benefits.

      CiteULike logo Connotea logo del.icio.us logo Digg logo Facebook logo Google logo Mendeley logo Reddit logo Twitter logo

    Related Content

    Similar Articles in:

    Citing Articles in:

    Navigate This Article